(Q70867084)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7260960%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

title

Synthesis and antitumor activity of 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)adriamycinone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7260960%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

author name string

D Horton

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7260960%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

W Priebe

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7260960%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

W R Turner

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7260960%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

publication date

1 July 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7260960%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

published in

Carbohydrate Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7260960%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7260960%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7260960%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

11-25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7260960%20AND%20SRC:MED&resulttype=core&format=json

Adriamycin analogs hydroxylated at C-3': synthesis and antitumor activity

14 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2985592-5

Synthesis and antitumor activity of sugar-ring hydroxyl analogues of daunorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2985592-5

7-O-(3-Amino-2,3,6-trideoxy-α-D-ribo-hexopyranosyl)daunomycinone, a configurational analog of daunorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2985592-5

Adriamycin analogs. 3. Synthesis of N-alkylated anthracyclines with enhanced efficacy and reduced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2985592-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2985592-5

Adriamycin. A new anticancer drug with significant clinical activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2985592-5

Stereocontrolled glycosidation of daunomycinone. Synthesis and biological evaluation of 6-hydroxy-L-arabino analogues of antitumor anthracyclines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2985592-5

Synthetic approaches to adriamycin. 2. Degradation of daunorubicin to a nonasymmetric tetracyclic ketone and refunctionalization of the A ring to adriamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2985592-5

Synthesis of 2,6-dideoxy-alpha-L-lyxo- and 2,6-dideoxy-alpha-L-arabino-hexopyranosyl halides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2985592-5

Synthesis of 2'-deoxy-L-fucopyranosylcarminomycinone and -epsilon-pyrromycinone as well as 2'-deoxy-D-erythro-pentopyranosyldaunomycinone, -carminomycinone, and -epsilon-pyrromycinone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2985592-5

New daunorubicin analogs. 3-Amino-2,3,6-trideoxy-.ALPHA.- and .BETA.-D-arabino- and 3,6-diamino-2,3,6-trideoxy-.ALPHA.-D-ribo-hexopyranosides of daunomycinone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2985592-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0008-6215(00)85592-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7260960%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference